The Indian primary market is gearing up for another exciting wave of listings. Adding fresh fuel to the ongoing IPO frenzy, the Securities and Exchange Board of India (SEBI) has given the green light to two major players: Cotec Healthcare and Deepa Jewellers. Here is a detailed look at the newest entrants in the upcoming IPO pipeline following their regulatory nods on 18 May 2026.
List of Latest IPO Approvals 22 May 2026
Below is the breakdown of the companies that have received SEBI approval on 22 May 2026:
Cotec Healthcare IPO Approval
Cotec Healthcare is India’s second-largest contract development and manufacturing organization (CDMO) in terms of the number of dosage forms. With a manufacturing facility in Roorkee, Uttarakhand, the company has capabilities across 24 distinct formulation types, providing off-patent products and complex generics to institutional and private customers. The IPO is structured as a combination of a fresh issue aggregating to INR 295 crore and an Offer for Sale (OFS) of 60 lakh shares by the promoters. Pantomath Capital Advisors is acting as the Book Running Lead Manager for the issue. The company submitted its DRHP on 19 September 2025. Following a detailed review, SEBI cleared the issue on 18 May 2026.
Deepa Jewellers IPO Approval
Deepa Jewellers operates as an organized B2B designer, processor, and wholesaler of hallmarked gold jewellery. Based out of Hyderabad, the company has a strong footprint across southern India, supplying 22-carat traditional and contemporary designs—including vaddanams and CNC machine-cut bangles—to major retail chains and standalone stores. Deepa Jewellers public issue is framed as a mix of a fresh issue worth INR 250 crore and an Offer for Sale (OFS) of up to 1.18 crore shares. Emkay Global has been appointed as the Lead Manager to the issue. Deepa Jewellers filed its prospectus on 2 January 2026, and secured its final regulatory nod on 18 May 2026.
Rajat Bhati has a strong technical background and 5 years of experience in the stock market. He focuses on equity research, technical analysis, IPO valuations, and risk management, helping investors make clearer, data-backed decisions. Today, he works full-time to educate people about the opportunities in IPO market.
